As of November 2024 I-Mab Biopharma has a market cap of NZ$0.14 Billion. This makes I-Mab Biopharma the world's 8925th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 14th, 2024 the market cap of I-Mab Biopharma was reported to be: